Page last updated: 2024-09-05

organophosphonates and DNA Virus Infections

organophosphonates has been researched along with DNA Virus Infections in 12 studies

Research

Studies (12)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (8.33)	18.2507
2000's	7 (58.33)	29.6817
2010's	3 (25.00)	24.3611
2020's	1 (8.33)	2.80

Authors

Authors	Studies
Alvarez-Cardona, JJ; Chemaly, RF; Whited, LK	1
Balzarini, J; Grabkowska-Drużyc, M; Piotrowska, DG	1
Florescu, DF; Keck, MA	1
Abbo, LM; Alencar, MC; Camargo, JF; Komanduri, KV; Lekakis, LJ; Morris, MI; Saneeymehri, S; Simkins, J	1
De Clercq, E; Snoeck, R	1
Holy, A	2
De Clercq, E	3
De Clercq, E; Holý, A	1
Zabawski, EJ	1

Reviews

9 review(s) available for organophosphonates and DNA Virus Infections

Article	Year
Brincidofovir: understanding its unique profile and potential role against adenovirus and other viral infections. Future microbiology, 2020, Volume: 15 Topics: Adenovirus Infections, Human; Animals; Antiviral Agents; Clinical Trials as Topic; Cytosine; DNA Virus Infections; DNA Viruses; Humans; Immunocompromised Host; Organophosphonates	2020
Role of cidofovir in the treatment of DNA virus infections, other than CMV infections, in immunocompromised patients. Current opinion in investigational drugs (London, England : 2000), 2002, Volume: 3, Issue:11 Topics: Cidofovir; Cytomegalovirus Infections; Cytosine; DNA Virus Infections; Humans; Immunocompromised Host; Organophosphonates; Organophosphorus Compounds	2002
Phosphonomethoxyalkyl analogs of nucleotides. Current pharmaceutical design, 2003, Volume: 9, Issue:31 Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; DNA Virus Infections; Drug Design; Hepatitis B; Humans; Nucleotides; Organophosphonates; Structure-Activity Relationship	2003
Clinical potential of the acyclic nucleoside phosphonates cidofovir, adefovir, and tenofovir in treatment of DNA virus and retrovirus infections. Clinical microbiology reviews, 2003, Volume: 16, Issue:4 Topics: Adenine; Animals; Cidofovir; Cytosine; DNA Virus Infections; DNA Viruses; Humans; Organophosphonates; Organophosphorus Compounds; Retroviridae; Retroviridae Infections; Reverse Transcriptase Inhibitors; Tenofovir	2003
Potential of acyclic nucleoside phosphonates in the treatment of DNA virus and retrovirus infections. Expert review of anti-infective therapy, 2003, Volume: 1, Issue:1 Topics: Adenine; Animals; Antiviral Agents; Cidofovir; Cytosine; Disease Models, Animal; DNA Virus Infections; Drug Resistance, Viral; Humans; Organophosphonates; Organophosphorus Compounds; Retroviridae Infections; Tenofovir	2003
Acyclic nucleoside phosphonates: a key class of antiviral drugs. Nature reviews. Drug discovery, 2005, Volume: 4, Issue:11 Topics: Animals; Antiviral Agents; DNA Virus Infections; Drug Design; Humans; Molecular Structure; Nucleosides; Organophosphonates	2005
Antiviral acyclic nucleoside phosphonates structure activity studies. Antiviral research, 2006, Volume: 71, Issue:2-3 Topics: Antiviral Agents; DNA Virus Infections; DNA Viruses; Humans; Nucleosides; Organophosphonates; Structure-Activity Relationship	2006
Acyclic nucleoside phosphonates in the chemotherapy of DNA virus and retrovirus infections. Intervirology, 1997, Volume: 40, Issue:5-6 Topics: Adenine; Animals; Anti-HIV Agents; Antiviral Agents; Cidofovir; Cytosine; DNA Virus Infections; Humans; Organophosphonates; Organophosphorus Compounds; Retroviridae Infections	1997
A review of topical and intralesional cidofovir. Dermatology online journal, 2000, Volume: 6, Issue:1 Topics: Administration, Topical; Animals; Antiviral Agents; Cidofovir; Cytosine; DNA Virus Infections; DNA Viruses; Humans; Injections, Intralesional; Organophosphonates; Organophosphorus Compounds; Skin Diseases, Viral	2000

Other Studies

3 other study(ies) available for organophosphonates and DNA Virus Infections

Article	Year
Design, synthesis, antiviral, and cytostatic evaluation of novel isoxazolidine analogues of C-nucleotides. Nucleosides, nucleotides & nucleic acids, 2013, Volume: 32, Issue:12 Topics: Antiviral Agents; Cycloaddition Reaction; Cytostatic Agents; DNA Virus Infections; DNA Viruses; Drug Design; Humans; Isoxazoles; Nucleotides; Organophosphonates; RNA Virus Infections; RNA Viruses	2013
Development of CMX001 (Brincidofovir) for the treatment of serious diseases or conditions caused by dsDNA viruses. Expert review of anti-infective therapy, 2014, Volume: 12, Issue:10 Topics: Adenoviridae; Antiviral Agents; Cytomegalovirus; Cytosine; DNA Virus Infections; Humans; Microbial Sensitivity Tests; Molluscum contagiosum virus; Organophosphonates; Orthopoxvirus; Polyomavirus	2014
The use of brincidofovir for the treatment of mixed dsDNA viral infection. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2016, Volume: 83 Topics: Adult; Antiviral Agents; BK Virus; Coinfection; Cytomegalovirus; Cytosine; DNA Virus Infections; Fatal Outcome; Female; Herpesvirus 4, Human; Humans; Immunocompromised Host; Organophosphonates; Stem Cell Transplantation; Viral Load; Young Adult	2016